Aptinyx Inc.
Aptinyx Inc. (APTX): 27 pipeline candidates · ~12 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
12.1 months
D/E 1.63 · 0% dilution
Lead: Approved
27 candidates
N/A
N/A
A transparent, data-derived signal for Aptinyx Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$44.8M
Quarterly Burn
$11.4M
Runway
12.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (27 candidates)
| Drug | Phase |
|---|---|
| abiraterone | Approved |
| amoxicillin | Approved |
| atomoxetine | Approved |
| axitinib | Approved |
| azithromycin | Approved |
| bicalutamide | Approved |
| bortezomib | Approved |
| bromfenac | Approved |
| candesartan cilexetil | Approved |
| celecoxib | Approved |
Showing 10 of 27 candidates. Sign up for full pipeline.
Frequently asked questions
How many drug candidates are in Aptinyx Inc.'s pipeline?
Aptinyx Inc. (APTX) has 27 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Aptinyx Inc.'s lead drug candidate?
Aptinyx Inc.'s most advanced tracked candidate is abiraterone (Approved) for 1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1 ) metastatic high-risk castration-sensitive prostate cancer (C.
What is Aptinyx Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Aptinyx Inc. has approximately 12.1 months of cash runway.
Who is the CEO of Aptinyx Inc.?
Washington Street is the chief executive officer of Aptinyx Inc. (APTX).
Get the full picture on Aptinyx Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.